Dr Srigadha Vivek Kumar
Current Work Location
Medicover Hospital, Myscape Rd, Beside The District Building, Financial District, Nanakramguda, Telangana 500032
Info
Dr Srigadha Vivek Kumar is a Consultant Medical Oncologist at Medicover Hospitals, Financial District, Hyderabad. He has 14 years of experience in cancer care. He specialises in diagnosing and treating different types of cancer. His interests include lung cancer, breast cancer, gastrointestinal cancers, blood cancers, bone marrow transplantation, and cellular therapy.
He is also experienced in chemotherapy, targeted therapy, and immunotherapy. He focuses on providing personalised treatment plans and compassionate care for every patient. He is fluent in Hindi and English and is registered with the Telangana State Medical Council (TS/03621).
Expertise & Treatments
Cancer Treatment Expertise
- Medical Oncology
- Thoracic Oncology (Lung Cancer)
- Breast Cancer Management
- Gastrointestinal (GI) Cancer Management
- Hematolymphoid Malignancies
- Personalized Cancer Treatment Planning
- Cancer Screening and Early Detection
- Advanced Cancer Care
- Precision Oncology
- Supportive and Palliative Oncology Care
Advanced Oncology Expertise
- Bone Marrow Transplantation
- Cellular Therapy
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Multidisciplinary Cancer Management
- Treatment Response Assessment
- Long-term Cancer Survivorship Care
Dr Srigadha Vivek Kumar is an experienced Medical Oncologist dedicated to helping patients through every stage of their cancer journey. He provides expert care for solid tumours, blood cancers, and complex oncology conditions. His goal is to deliver effective treatment while improving his patients' quality of life.
With advanced training in medical oncology , he offers modern cancer treatments such as chemotherapy, immunotherapy, targeted therapy, and bone marrow transplant care. Patients seeking expert cancer consultation in Financial District, Nanakramguda, or Hyderabad can consult Dr Vivek Kumar at Medicover Hospitals for comprehensive cancer evaluation, treatment planning, and long-term follow-up care.
Past Experience
- Consultant Medical Oncologist, Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam (2026)
- Assistant Professor (Ad-hoc), Department of Medical Oncology, Tata Memorial Hospital, Mumbai (2025-2026)
- Senior Resident, Medical Oncology, Tata Memorial Hospital, Mumbai (2025-2026)
- Senior Resident, Internal Medicine, Nizam's Institute of Medical Sciences (NIMS), Hyderabad (2021-2022)
Academic & Training Contributions
- DM Medical Oncology, Tata Memorial Hospital, Mumbai (2022-2025)
- MD Internal Medicine, Nizam's Institute of Medical Sciences (NIMS), Hyderabad (2018-2021)
- MBBS, Osmania Medical College, Hyderabad (2011-2017)
- Clinical training in Medical Oncology, Chemotherapy, Targeted Therapy, Immunotherapy, Bone Marrow Transplantation, and Cellular Therapy
- Active participation in oncology research and evidence-based cancer care
- Contributor to peer-reviewed oncology publications
- Advanced training in thoracic oncology, breast oncology, gastrointestinal malignancies, and hematological cancers
- Harvard Medical School Executive Education Certificate in Advanced Management of Oncological Diseases (2026)
Awards & Achievements
- Harvard Medical School Executive Education Certificate in Advanced Management of Oncological Diseases (2026)
- Served as Assistant Professor (Ad-hoc), Medical Oncology, Tata Memorial Hospital, Mumbai
- Published multiple research articles in leading national and international oncology journals
- Member of the Indian Society of Medical & Paediatric Oncology (ISMPO)
- Member of the European Society for Medical Oncology (ESMO)
- Srigadha Vivek K., Prabhash K., Noronha V., Joshi A., Patil V.M., Menon N., Singh A.K., Shah M.
Cabozantinib: A Narrative Drug Review. Cancer Research, Statistics, and Treatment. 2023;6(1):74-87. - Kumar Srigadha, Noronha V., Prabhash K.
Authors' Reply to Bhattacharya. Cancer Research, Statistics, and Treatment. 2023;6:344-345. - Noronha V., Sahu H., Kapoor A., Patil V., Menon N., Shah M., Davis D., Roy R., Vivek S., et al.
Reduced Frequency Dosing of Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Real-World Data. Ecancermedicalscience. 2024;18:1721. - Noronha V., Patil V.M., Menon N., Joshi A., Shah M.J., Singh A., et al., Kumar S.V.
Phase III Randomized Trial Comparing Neoadjuvant Paclitaxel Plus Platinum with 5-Fluorouracil Plus Platinum in Esophageal or Gastroesophageal Junction Squamous Cell Carcinoma. Journal of the National Cancer Institute. 2025;117(1):58-75. - Srigadha Vivek Kumar, Seema Gulia, Prabhat Bhargava, Sushmita Rath, Tanuja Shet, Nita Nair, Sangeeta Desai, Asawari Patil, Shalaka Joshi, Palak Popat, Sudeep Gupta
Retrospective and Prospective Analysis of Microinvasive Breast Cancer: Clinicopathological Features, Treatment and Outcome. - Anokhi Shah, S.S. Addagalla, S. Rath, V. Srigadha, B. Rekhi, N. Khanna, et al.
Systemic Therapy Effectiveness in Metastatic Non-Uterine Leiomyosarcoma: A Decade of Real-World Outcomes from an Indian Cohort.
Book Oncologist Consultation
October 2026
Frequently Asked Questions
Dr Srigadha Vivek Kumar is a Consultant Medical Oncologist with 14 years of experience in cancer care. He specializes in the diagnosis, treatment, and management of various cancers and currently practices at Medicover Hospitals, Financial District, Hyderabad.
He treats a wide range of cancers, including lung cancer, breast cancer, gastrointestinal cancers, leukemia, lymphoma, multiple myeloma, and other blood-related cancers.
Yes. He is experienced in planning, administering, and monitoring chemotherapy for various cancer types.
Yes. Dr Vivek Kumar specializes in modern cancer treatments, including immunotherapy, targeted therapy, precision oncology, and personalized cancer treatment plans.
Yes. He has expertise in bone marrow transplantation and cellular therapy for suitable cancer and blood disorder patients.
Yes. Patients can consult him for cancer diagnosis review, treatment planning, and second opinions before starting or changing treatment.
His special interests include thoracic oncology (lung cancer), breast cancer, gastrointestinal malignancies, hematolymphoid malignancies, bone marrow transplantation, and advanced systemic therapies.
He communicates fluently in Hindi and English, making consultations comfortable for a wide range of patients.
You can consult Dr Vivek Kumar at Medicover Hospitals, Financial District, Nanakramguda, Hyderabad, for cancer evaluation, treatment planning, chemotherapy, immunotherapy, targeted therapy, and follow-up cancer care.